nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—CYP2D6—Parkinson's disease	0.627	1	CbGaD
Irbesartan—JUN—adrenal medulla—Parkinson's disease	0.0297	0.274	CbGeAlD
Irbesartan—JUN—peripheral nervous system—Parkinson's disease	0.00958	0.0885	CbGeAlD
Irbesartan—JUN—nerve—Parkinson's disease	0.00747	0.069	CbGeAlD
Irbesartan—JUN—hindbrain—Parkinson's disease	0.00559	0.0517	CbGeAlD
Irbesartan—JUN—embryo—Parkinson's disease	0.0035	0.0323	CbGeAlD
Irbesartan—JUN—brainstem—Parkinson's disease	0.00321	0.0296	CbGeAlD
Irbesartan—JUN—forebrain—Parkinson's disease	0.00309	0.0286	CbGeAlD
Irbesartan—JUN—cardiovascular system—Parkinson's disease	0.00262	0.0242	CbGeAlD
Irbesartan—EDNRA—medulla oblongata—Parkinson's disease	0.00245	0.0226	CbGeAlD
Irbesartan—AGTR1—forebrain—Parkinson's disease	0.00233	0.0215	CbGeAlD
Irbesartan—EDNRA—midbrain—Parkinson's disease	0.00224	0.0207	CbGeAlD
Irbesartan—JUN—medulla oblongata—Parkinson's disease	0.00224	0.0207	CbGeAlD
Irbesartan—JUN—midbrain—Parkinson's disease	0.00204	0.0189	CbGeAlD
Irbesartan—JUN—spinal cord—Parkinson's disease	0.00199	0.0184	CbGeAlD
Irbesartan—AGTR1—cardiovascular system—Parkinson's disease	0.00197	0.0182	CbGeAlD
Irbesartan—JUN—head—Parkinson's disease	0.00177	0.0164	CbGeAlD
Irbesartan—AGTR1—medulla oblongata—Parkinson's disease	0.00168	0.0156	CbGeAlD
Irbesartan—JUN—nervous system—Parkinson's disease	0.00168	0.0155	CbGeAlD
Irbesartan—JUN—central nervous system—Parkinson's disease	0.00162	0.0149	CbGeAlD
Irbesartan—JUN—cerebellum—Parkinson's disease	0.00158	0.0146	CbGeAlD
Irbesartan—CYP2D6—hindbrain—Parkinson's disease	0.00152	0.0141	CbGeAlD
Irbesartan—EDNRA—brain—Parkinson's disease	0.00141	0.013	CbGeAlD
Irbesartan—AGTR1—head—Parkinson's disease	0.00133	0.0123	CbGeAlD
Irbesartan—JUN—brain—Parkinson's disease	0.00128	0.0119	CbGeAlD
Irbesartan—AGTR1—nervous system—Parkinson's disease	0.00126	0.0117	CbGeAlD
Irbesartan—AGTR1—central nervous system—Parkinson's disease	0.00122	0.0112	CbGeAlD
Irbesartan—PTGS1—forebrain—Parkinson's disease	0.00102	0.00946	CbGeAlD
Irbesartan—AGTR1—brain—Parkinson's disease	0.000967	0.00893	CbGeAlD
Irbesartan—CYP2C9—cardiovascular system—Parkinson's disease	0.000949	0.00876	CbGeAlD
Irbesartan—CYP2D6—brainstem—Parkinson's disease	0.000872	0.00806	CbGeAlD
Irbesartan—PTGS1—cardiovascular system—Parkinson's disease	0.000866	0.008	CbGeAlD
Irbesartan—CYP2D6—forebrain—Parkinson's disease	0.000842	0.00778	CbGeAlD
Irbesartan—PTGS1—spinal cord—Parkinson's disease	0.00066	0.0061	CbGeAlD
Irbesartan—PTGS1—head—Parkinson's disease	0.000587	0.00542	CbGeAlD
Irbesartan—PTGS1—nervous system—Parkinson's disease	0.000556	0.00514	CbGeAlD
Irbesartan—PTGS1—central nervous system—Parkinson's disease	0.000535	0.00495	CbGeAlD
Irbesartan—CYP2C8—brain—Parkinson's disease	0.000524	0.00484	CbGeAlD
Irbesartan—CYP2D6—head—Parkinson's disease	0.000482	0.00445	CbGeAlD
Irbesartan—CYP3A4—nervous system—Parkinson's disease	0.000465	0.00429	CbGeAlD
Irbesartan—CYP2D6—nervous system—Parkinson's disease	0.000457	0.00422	CbGeAlD
Irbesartan—CYP3A4—central nervous system—Parkinson's disease	0.000447	0.00413	CbGeAlD
Irbesartan—CYP2D6—central nervous system—Parkinson's disease	0.00044	0.00407	CbGeAlD
Irbesartan—CYP2D6—cerebellum—Parkinson's disease	0.00043	0.00397	CbGeAlD
Irbesartan—PTGS1—brain—Parkinson's disease	0.000425	0.00393	CbGeAlD
Irbesartan—CYP2D6—brain—Parkinson's disease	0.000349	0.00323	CbGeAlD
Irbesartan—UGT1A3—Metabolism—CYP2E1—Parkinson's disease	5.82e-05	0.00022	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—NQO1—Parkinson's disease	5.76e-05	0.000218	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	5.76e-05	0.000217	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—DRD1—Parkinson's disease	5.75e-05	0.000217	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—DDC—Parkinson's disease	5.73e-05	0.000217	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—TH—Parkinson's disease	5.68e-05	0.000215	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GCH1—Parkinson's disease	5.66e-05	0.000214	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—IL6—Parkinson's disease	5.65e-05	0.000213	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—DRD3—Parkinson's disease	5.57e-05	0.00021	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—COMT—Parkinson's disease	5.51e-05	0.000208	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	5.49e-05	0.000207	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	5.47e-05	0.000207	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MCCC1—Parkinson's disease	5.47e-05	0.000207	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ND3—Parkinson's disease	5.47e-05	0.000207	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CYCS—Parkinson's disease	5.45e-05	0.000206	CbGpPWpGaD
Irbesartan—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	5.44e-05	0.000205	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MCCC1—Parkinson's disease	5.42e-05	0.000205	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ND3—Parkinson's disease	5.42e-05	0.000205	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GSTA4—Parkinson's disease	5.41e-05	0.000205	CbGpPWpGaD
Irbesartan—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	5.41e-05	0.000204	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IGF2—Parkinson's disease	5.38e-05	0.000203	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	5.35e-05	0.000202	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—FGF20—Parkinson's disease	5.29e-05	0.0002	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ADRBK1—Parkinson's disease	5.2e-05	0.000197	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IGF1R—Parkinson's disease	5.2e-05	0.000197	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—TALDO1—Parkinson's disease	5.14e-05	0.000194	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—OMD—Parkinson's disease	5.14e-05	0.000194	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—EDN1—Parkinson's disease	5.14e-05	0.000194	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ADORA2A—Parkinson's disease	5.13e-05	0.000194	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.11e-05	0.000193	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—TALDO1—Parkinson's disease	5.1e-05	0.000193	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—OMD—Parkinson's disease	5.1e-05	0.000193	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GBA—Parkinson's disease	5.05e-05	0.000191	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—DBH—Parkinson's disease	5.05e-05	0.000191	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—FBP1—Parkinson's disease	5.05e-05	0.000191	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	5.04e-05	0.00019	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—DRD2—Parkinson's disease	5.04e-05	0.00019	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR7—Parkinson's disease	5.04e-05	0.00019	CbGpPWpGaD
Irbesartan—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	4.97e-05	0.000188	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.92e-05	0.000186	CbGpPWpGaD
Irbesartan—JUN—Immune System—ABL1—Parkinson's disease	4.9e-05	0.000185	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PLA2G6—Parkinson's disease	4.88e-05	0.000184	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.87e-05	0.000184	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	4.83e-05	0.000183	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—MAOB—Parkinson's disease	4.83e-05	0.000182	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—COMT—Parkinson's disease	4.83e-05	0.000182	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GSTP1—Parkinson's disease	4.8e-05	0.000182	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—MAOA—Parkinson's disease	4.79e-05	0.000181	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—HMOX1—Parkinson's disease	4.74e-05	0.000179	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—INSR—Parkinson's disease	4.73e-05	0.000179	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NGF—Parkinson's disease	4.72e-05	0.000178	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GCH1—Parkinson's disease	4.65e-05	0.000176	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ND3—Parkinson's disease	4.63e-05	0.000175	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MCCC1—Parkinson's disease	4.63e-05	0.000175	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GCH1—Parkinson's disease	4.61e-05	0.000174	CbGpPWpGaD
Irbesartan—JUN—Immune System—HGF—Parkinson's disease	4.61e-05	0.000174	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	4.59e-05	0.000174	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ABCB1—Parkinson's disease	4.55e-05	0.000172	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—IL6—Parkinson's disease	4.54e-05	0.000172	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HTR2A—Parkinson's disease	4.5e-05	0.00017	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—FGB—Parkinson's disease	4.47e-05	0.000169	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR1A—Parkinson's disease	4.45e-05	0.000168	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GSTM1—Parkinson's disease	4.41e-05	0.000167	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TAC1—Parkinson's disease	4.38e-05	0.000166	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—OMD—Parkinson's disease	4.35e-05	0.000165	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TALDO1—Parkinson's disease	4.35e-05	0.000165	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—DRD1—Parkinson's disease	4.3e-05	0.000162	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GPX1—Parkinson's disease	4.23e-05	0.00016	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IGF2—Parkinson's disease	4.22e-05	0.00016	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—APOE—Parkinson's disease	4.18e-05	0.000158	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—DRD3—Parkinson's disease	4.16e-05	0.000157	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.16e-05	0.000157	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GBA—Parkinson's disease	4.14e-05	0.000157	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—FBP1—Parkinson's disease	4.14e-05	0.000157	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—DBH—Parkinson's disease	4.14e-05	0.000157	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	4.13e-05	0.000156	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GBA—Parkinson's disease	4.11e-05	0.000155	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—DBH—Parkinson's disease	4.11e-05	0.000155	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—FBP1—Parkinson's disease	4.11e-05	0.000155	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IGF1R—Parkinson's disease	4.08e-05	0.000154	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—EDN1—Parkinson's disease	4.03e-05	0.000152	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GCH1—Parkinson's disease	3.94e-05	0.000149	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—MTHFR—Parkinson's disease	3.9e-05	0.000147	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ADRBK1—Parkinson's disease	3.89e-05	0.000147	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—MAPK8—Parkinson's disease	3.8e-05	0.000144	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—DRD2—Parkinson's disease	3.76e-05	0.000142	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR7—Parkinson's disease	3.76e-05	0.000142	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NGF—Parkinson's disease	3.71e-05	0.00014	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—DDC—Parkinson's disease	3.7e-05	0.00014	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—APOE—Parkinson's disease	3.63e-05	0.000137	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CYP2D6—Parkinson's disease	3.59e-05	0.000136	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ND3—Parkinson's disease	3.57e-05	0.000135	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.57e-05	0.000135	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—INS—Parkinson's disease	3.57e-05	0.000135	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.55e-05	0.000134	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HTR2A—Parkinson's disease	3.53e-05	0.000133	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CTGF—Parkinson's disease	3.52e-05	0.000133	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—FBP1—Parkinson's disease	3.51e-05	0.000133	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—DBH—Parkinson's disease	3.51e-05	0.000133	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GBA—Parkinson's disease	3.51e-05	0.000133	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTA4—Parkinson's disease	3.5e-05	0.000132	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.45e-05	0.000131	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—OMD—Parkinson's disease	3.36e-05	0.000127	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.36e-05	0.000127	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CYP2E1—Parkinson's disease	3.28e-05	0.000124	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APOE—Parkinson's disease	3.28e-05	0.000124	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—NQO1—Parkinson's disease	3.24e-05	0.000123	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—TH—Parkinson's disease	3.2e-05	0.000121	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.19e-05	0.00012	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IGF2—Parkinson's disease	3.15e-05	0.000119	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	3.15e-05	0.000119	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MAOB—Parkinson's disease	3.12e-05	0.000118	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—INS—Parkinson's disease	3.1e-05	0.000117	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CYCS—Parkinson's disease	3.07e-05	0.000116	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IGF1R—Parkinson's disease	3.05e-05	0.000115	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—DDC—Parkinson's disease	3.04e-05	0.000115	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.04e-05	0.000115	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—DDC—Parkinson's disease	3.01e-05	0.000114	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—EDN1—Parkinson's disease	3.01e-05	0.000114	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.97e-05	0.000112	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.87e-05	0.000109	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTA4—Parkinson's disease	2.85e-05	0.000108	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.81e-05	0.000106	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—INS—Parkinson's disease	2.8e-05	0.000106	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NGF—Parkinson's disease	2.77e-05	0.000105	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—COMT—Parkinson's disease	2.72e-05	0.000103	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DBH—Parkinson's disease	2.71e-05	0.000102	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.71e-05	0.000102	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GBA—Parkinson's disease	2.71e-05	0.000102	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GSTP1—Parkinson's disease	2.71e-05	0.000102	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—MAOA—Parkinson's disease	2.7e-05	0.000102	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—HMOX1—Parkinson's disease	2.67e-05	0.000101	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CASP3—Parkinson's disease	2.66e-05	0.0001	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL6—Parkinson's disease	2.64e-05	9.98e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HTR2A—Parkinson's disease	2.64e-05	9.96e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.59e-05	9.77e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—DDC—Parkinson's disease	2.58e-05	9.73e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	2.56e-05	9.69e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ABCB1—Parkinson's disease	2.56e-05	9.68e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.56e-05	9.67e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MAOB—Parkinson's disease	2.54e-05	9.59e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GSTM1—Parkinson's disease	2.49e-05	9.4e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOE—Parkinson's disease	2.45e-05	9.26e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MAPK8—Parkinson's disease	2.44e-05	9.23e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTA4—Parkinson's disease	2.43e-05	9.19e-05	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IL6—Parkinson's disease	2.43e-05	9.18e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1B—Parkinson's disease	2.42e-05	9.13e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.41e-05	9.13e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.4e-05	9.08e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GPX1—Parkinson's disease	2.38e-05	9e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	2.32e-05	8.76e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CTGF—Parkinson's disease	2.27e-05	8.59e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—MAPK8—Parkinson's disease	2.22e-05	8.37e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—MTHFR—Parkinson's disease	2.2e-05	8.3e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	2.19e-05	8.28e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MAOB—Parkinson's disease	2.17e-05	8.19e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	2.12e-05	8.01e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NQO1—Parkinson's disease	2.1e-05	7.92e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—INS—Parkinson's disease	2.09e-05	7.91e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CASP3—Parkinson's disease	2.09e-05	7.88e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6—Parkinson's disease	2.07e-05	7.83e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—TH—Parkinson's disease	2.07e-05	7.8e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.06e-05	7.8e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOE—Parkinson's disease	2.05e-05	7.73e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DDC—Parkinson's disease	1.99e-05	7.51e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYCS—Parkinson's disease	1.98e-05	7.49e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MAPK8—Parkinson's disease	1.92e-05	7.25e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.89e-05	7.13e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.88e-05	7.09e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.87e-05	7.06e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.85e-05	7e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—COMT—Parkinson's disease	1.76e-05	6.64e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTP1—Parkinson's disease	1.75e-05	6.6e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—INS—Parkinson's disease	1.75e-05	6.6e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MAOA—Parkinson's disease	1.74e-05	6.59e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.74e-05	6.57e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.72e-05	6.52e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—HMOX1—Parkinson's disease	1.72e-05	6.51e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.72e-05	6.5e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.71e-05	6.44e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—TH—Parkinson's disease	1.7e-05	6.41e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.69e-05	6.39e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—TH—Parkinson's disease	1.68e-05	6.35e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.67e-05	6.32e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ABCB1—Parkinson's disease	1.65e-05	6.25e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.63e-05	6.15e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.61e-05	6.1e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.61e-05	6.09e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTM1—Parkinson's disease	1.61e-05	6.07e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.58e-05	5.98e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—Parkinson's disease	1.56e-05	5.9e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CASP3—Parkinson's disease	1.56e-05	5.89e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GPX1—Parkinson's disease	1.54e-05	5.81e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.47e-05	5.57e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.46e-05	5.51e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—COMT—Parkinson's disease	1.44e-05	5.45e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TH—Parkinson's disease	1.44e-05	5.43e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.43e-05	5.42e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MAPK8—Parkinson's disease	1.43e-05	5.41e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.43e-05	5.41e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—COMT—Parkinson's disease	1.43e-05	5.4e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.42e-05	5.38e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MTHFR—Parkinson's disease	1.42e-05	5.36e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.42e-05	5.36e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.41e-05	5.35e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—Parkinson's disease	1.41e-05	5.35e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.4e-05	5.3e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.38e-05	5.21e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.36e-05	5.13e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.35e-05	5.09e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOE—Parkinson's disease	1.32e-05	4.99e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.32e-05	4.98e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.31e-05	4.94e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.26e-05	4.77e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.25e-05	4.73e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.24e-05	4.7e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—Parkinson's disease	1.22e-05	4.63e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—COMT—Parkinson's disease	1.22e-05	4.62e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.22e-05	4.61e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.22e-05	4.59e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.21e-05	4.58e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.2e-05	4.53e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.17e-05	4.4e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.16e-05	4.37e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.15e-05	4.35e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.14e-05	4.3e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—INS—Parkinson's disease	1.13e-05	4.27e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.12e-05	4.25e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.12e-05	4.22e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TH—Parkinson's disease	1.11e-05	4.19e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOE—Parkinson's disease	1.08e-05	4.1e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOE—Parkinson's disease	1.08e-05	4.06e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GPX1—Parkinson's disease	1.07e-05	4.04e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.06e-05	4.02e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MTHFR—Parkinson's disease	9.87e-06	3.73e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—COMT—Parkinson's disease	9.42e-06	3.56e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTP1—Parkinson's disease	9.38e-06	3.55e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MAOA—Parkinson's disease	9.36e-06	3.54e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—INS—Parkinson's disease	9.27e-06	3.5e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HMOX1—Parkinson's disease	9.25e-06	3.5e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOE—Parkinson's disease	9.19e-06	3.47e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—INS—Parkinson's disease	9.19e-06	3.47e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—Parkinson's disease	9.15e-06	3.46e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ABCB1—Parkinson's disease	8.88e-06	3.36e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTM1—Parkinson's disease	8.62e-06	3.26e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GPX1—Parkinson's disease	8.25e-06	3.12e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—INS—Parkinson's disease	7.85e-06	2.97e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MTHFR—Parkinson's disease	7.62e-06	2.88e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOE—Parkinson's disease	7.09e-06	2.68e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—INS—Parkinson's disease	6.06e-06	2.29e-05	CbGpPWpGaD
